Skip to main content
Clinical Trials/NL-OMON31844
NL-OMON31844Not yet recruitingNot Applicable

Effects of bilateral subthalamic nucleus deep brain stimulation on plasma triglycerides and glucose metabolism in patients with advanced Parkinson*s disease. - Effects of subthalamic nucleus stimulation on metabolism

Academisch Medisch Centrum0 sites10 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients with idiopathic Parkinson's disease, bilateral subthalamic nucleus deep brain stimulation, and a documented effect of bilateral subthalamic nucleus deep brain stimulation on parkinsonism *measured with the Unified Parkinson*s disease Rating Scale (UPDRS) motor section*equal or more than 75% of the difference between the preoperative provoked OFF and ON phases.

Exclusion Criteria

  • Age less than 18 years, other functional stereotactic neurosurgical interventions (e.g. pallidotomy), psychosis, depression, alcoholism, dyslipidemia (primary or secondary form), use of lipid lowering drugs, unstable weight, presence of type II diabetes mellitus, former history of diabetes gravidarum, first line familial preponderance of type II diabetes mellitus, active smoking, renal insufficiency (creatinine > 150 umol/L, creatinine clearance <60 ml/min) or elevated liver enzymes (2x upper limit).

Investigators

Similar Trials